Total Funding
57
Total FundingSeries C raised
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
44675
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Guillaume Pfefer: Chief Executive OfficerPast Role: Sanofi Pasteur, General Manager
David Kolesky: Co-founderPast Role: Wyss Institute, Technology Development Fellow
About the Company
Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease.
The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define health and disease, providing medical professionals with novel medications and delivery methods.
Senda Biosciences was
established in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts.
